Streetbeat News

Revenues

FOXA

FOX News Digital reported double-digit gains in Q3 2024, leading all news brands in multiplatform views and minutes. It saw a 31% year-over-year growth in total digital multiplatform uniques, narrowing the gap with CNN.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 7:03 am

EWQ

The Harmonised Index of Consumer Prices (HICP) in France for September decreased by 1.3% month-over-month, which is slightly more than the estimated decrease of 1.2%. The previous month's HICP was at 1.2%.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 7:01 am

CMCSA

NBCUniversal, a subsidiary of Comcast Corp (NASDAQ:CMCSA), is undergoing a major restructuring of its advertising team, with key leadership changes and a new strategy for sports and Olympics sales. This move aims to enhance market share and streamline operations.

Portfolio Pulse from Benzinga Neuro

October 15, 2024 | 6:52 am

TVGN

Tevogen's CEO has reaffirmed the company's commitment to transparency regarding its multi-billion-dollar assets following the release of revenue projections.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 6:32 am

DIS

WBD

Warner Bros.' 'Joker: Folie À Deux' is projected to lose up to $200 million due to poor box office performance, contrasting sharply with the success of the original 'Joker' film. The sequel's shift to a musical tone may have alienated fans, impacting Warner Bros.' stock.

Portfolio Pulse from Ananya Gairola

October 15, 2024 | 6:11 am

EWU

The U.K. Average Earnings Index, including bonuses, for August was reported at 3.8%, matching the estimated figure and showing a decrease from the revised prior figure of 4.1%.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 6:03 am

ERIC

Ericsson forecasts its Q4 adjusted gross margin for Networks to be between 47%-49%, with sales growth for Networks and Cloud Software expected to fall below the three-year seasonal average.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 5:36 am

ARGX

argenx presented data at the 2024 AANEM and MGFA Scientific Session showing the positive impact of its immunology programs, particularly VYVGART, on patients. The data highlights the drug's speed of onset, depth, and durability of response, along with a favorable safety profile. Real-world data indicates a significant reduction in steroid use among gMG patients using VYVGART. argenx is also expanding its neurology pipeline with new programs.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 5:28 am

BBJP

DXJ

EWJ

Japan's industrial production for August decreased by 3.3% month-over-month, matching both the estimated and prior figures.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 5:05 am

NFLX

SONY

SPOT

Jefferies identifies Netflix, Sony, and Bandai Namco as key beneficiaries of the booming anime industry, expected to reach $60 billion by 2030. The growth is driven by increased anime distribution on streaming platforms and licensing revenues.

Portfolio Pulse from Benzinga Neuro

October 15, 2024 | 3:34 am